Annual Shareholders Equity
$27.72 M
-$11.64 M-29.58%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual stockholders equity is $27.72 million, with the most recent change of -$11.64 million (-29.58%) on June 30, 2024.
- During the last 3 years, AYTU annual shareholders equity has fallen by -$109.85 million (-79.85%).
- AYTU annual shareholders equity is now -79.85% below its all-time high of $137.57 million, reached on June 30, 2021.
Performance
AYTU Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$29.83 M
+$2.11 M+7.61%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly stockholders equity is $29.83 million, with the most recent change of +$2.11 million (+7.61%) on September 30, 2024.
- Over the past year, AYTU quarterly shareholders equity has dropped by -$2.34 million (-7.28%).
- AYTU quarterly shareholders equity is now -79.16% below its all-time high of $143.15 million, reached on March 31, 2021.
Performance
AYTU Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AYTU Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.6% | -7.3% |
| 3 y3 years | -79.8% | -73.3% |
| 5 y5 years | +291.0% | -79.2% |
AYTU Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.8% | at low | -71.7% | +7.6% |
| 5 y | 5-year | -79.8% | +291.0% | -79.2% | +74.5% |
| alltime | all time | -79.8% | >+9999.0% | -79.2% | >+9999.0% |
Aytu BioPharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.83 M(+7.6%) |
| Jun 2024 | $27.72 M(-29.6%) | $27.72 M(-9.9%) |
| Mar 2024 | - | $30.78 M(-6.3%) |
| Dec 2023 | - | $32.85 M(+2.1%) |
| Sep 2023 | - | $32.17 M(-18.3%) |
| Jun 2023 | $39.36 M(-11.2%) | $39.36 M(-3.8%) |
| Mar 2023 | - | $40.91 M(-10.7%) |
| Dec 2022 | - | $45.82 M(-15.0%) |
| Sep 2022 | - | $53.91 M(+21.7%) |
| Jun 2022 | $44.31 M(-67.8%) | $44.31 M(-27.5%) |
| Mar 2022 | - | $61.14 M(-42.1%) |
| Dec 2021 | - | $105.54 M(-5.3%) |
| Sep 2021 | - | $111.50 M(-18.9%) |
| Jun 2021 | $137.57 M(+44.8%) | $137.57 M(-3.9%) |
| Mar 2021 | - | $143.15 M(+27.0%) |
| Dec 2020 | - | $112.69 M(+23.8%) |
| Sep 2020 | - | $91.06 M(-4.2%) |
| Jun 2020 | $95.02 M(+1240.5%) | $95.02 M(+10.9%) |
| Mar 2020 | - | $85.70 M(+401.5%) |
| Dec 2019 | - | $17.09 M(+635.4%) |
| Sep 2019 | - | $2.32 M(-67.2%) |
| Jun 2019 | $7.09 M(-47.2%) | $7.09 M(-55.8%) |
| Mar 2019 | - | $16.04 M(-19.4%) |
| Dec 2018 | - | $19.90 M(+96.4%) |
| Sep 2018 | - | $10.13 M(-24.5%) |
| Jun 2018 | $13.42 M(+235.6%) | $13.42 M(+5.3%) |
| Mar 2018 | - | $12.75 M(+320.7%) |
| Dec 2017 | - | $3.03 M(-52.3%) |
| Sep 2017 | - | $6.35 M(+58.8%) |
| Jun 2017 | $4.00 M(-60.3%) | $4.00 M(-53.1%) |
| Mar 2017 | - | $8.52 M(-18.4%) |
| Dec 2016 | - | $10.45 M(+45.4%) |
| Sep 2016 | - | $7.19 M(-28.7%) |
| Jun 2016 | $10.09 M | $10.09 M(-42.6%) |
| Mar 2016 | - | $17.57 M(+15.1%) |
| Dec 2015 | - | $15.26 M(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $13.41 M(-14.1%) |
| Jun 2015 | $15.62 M(<-9900.0%) | $15.62 M(+2732.7%) |
| Mar 2015 | - | $551.30 K(-1142.2%) |
| Feb 2015 | - | -$52.90 K(+20.0%) |
| Nov 2014 | - | -$44.10 K(-2.0%) |
| Aug 2014 | -$45.00 K(-100.8%) | -$45.00 K(+25.0%) |
| Jun 2014 | $5.37 M(-4941.7%) | - |
| May 2014 | - | -$36.00 K(-75.6%) |
| Feb 2014 | - | -$147.80 K(+17.1%) |
| Nov 2013 | - | -$126.20 K(+13.8%) |
| Aug 2013 | -$110.90 K(+59.1%) | -$110.90 K(+4.6%) |
| May 2013 | - | -$106.00 K(+11.8%) |
| Feb 2013 | - | -$94.80 K(+15.3%) |
| Nov 2012 | - | -$82.20 K(+17.9%) |
| Aug 2012 | -$69.70 K(+95.8%) | -$69.70 K(+27.0%) |
| May 2012 | - | -$54.90 K(+10.9%) |
| Feb 2012 | - | -$49.50 K(+4.0%) |
| Nov 2011 | - | -$47.60 K(+33.7%) |
| Aug 2011 | -$35.60 K(-36.0%) | -$35.60 K(-6.3%) |
| May 2011 | - | -$38.00 K(+57.7%) |
| Feb 2011 | - | -$24.10 K(-64.2%) |
| Nov 2010 | - | -$67.40 K(+21.2%) |
| Aug 2010 | -$55.60 K(+308.8%) | -$55.60 K(+15.8%) |
| May 2010 | - | -$48.00 K(+15.7%) |
| Feb 2010 | - | -$41.50 K(+31.3%) |
| Nov 2009 | - | -$31.60 K(+132.4%) |
| Aug 2009 | -$13.60 K(-152.3%) | -$13.60 K(+10.6%) |
| May 2009 | - | -$12.30 K(+24.2%) |
| Feb 2009 | - | -$9900.00(-419.4%) |
| Nov 2008 | - | $3100.00(-88.1%) |
| Aug 2008 | $26.00 K(+38.3%) | $26.00 K(-31.2%) |
| May 2008 | - | $37.80 K(-30.8%) |
| Feb 2008 | - | $54.60 K(-15.2%) |
| Nov 2007 | - | $64.40 K(+242.6%) |
| Aug 2007 | $18.80 K | $18.80 K(-35.2%) |
| May 2007 | - | $29.00 K |
FAQ
- What is Aytu BioPharma annual stockholders equity?
- What is the all time high annual shareholders equity for Aytu BioPharma?
- What is Aytu BioPharma annual shareholders equity year-on-year change?
- What is Aytu BioPharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aytu BioPharma?
- What is Aytu BioPharma quarterly shareholders equity year-on-year change?
What is Aytu BioPharma annual stockholders equity?
The current annual shareholders equity of AYTU is $27.72 M
What is the all time high annual shareholders equity for Aytu BioPharma?
Aytu BioPharma all-time high annual stockholders equity is $137.57 M
What is Aytu BioPharma annual shareholders equity year-on-year change?
Over the past year, AYTU annual stockholders equity has changed by -$11.64 M (-29.58%)
What is Aytu BioPharma quarterly stockholders equity?
The current quarterly shareholders equity of AYTU is $29.83 M
What is the all time high quarterly shareholders equity for Aytu BioPharma?
Aytu BioPharma all-time high quarterly stockholders equity is $143.15 M
What is Aytu BioPharma quarterly shareholders equity year-on-year change?
Over the past year, AYTU quarterly stockholders equity has changed by -$2.34 M (-7.28%)